Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorth Atl.smlr Regulatory News (NAS)

Share Price Information for North Atl.smlr (NAS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,050.00
Bid: 4,010.00
Ask: 4,040.00
Change: -20.00 (-0.49%)
Spread: 30.00 (0.748%)
Open: 3,980.00
High: 4,050.00
Low: 3,980.00
Prev. Close: 4,070.00
NAS Live PriceLast checked at -
North Atlantic Smaller Companies is an Investment Trust

To provide capital appreciation through investment in a portfolio of smaller companies principally based in countries bordering the North Atlantic Ocean.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half Yearly Report

10 Sep 2015 18:15

RNS Number : 7517Y
North Atlantic Smlr Co Inv Tst PLC
10 September 2015
 



North Atlantic Smaller Companies Investment Trust plc

Half-Yearly Report for the six months ended 31 July 2015

 

objective of the company and financial highlights

The objective of the Company is to provide capital appreciation through investment in a portfolio of smaller companies principally based in countries bordering the North Atlantic Ocean.

31 July2015

(unaudited)

31 January2015

(audited)

%

Change

Net asset value per 5p Ordinary Share*:

 

 

 

Basic

2,527p

2,262p

11.7

Diluted

2,525p

2,259p

11.8

Basic adjusted#‡

2,568p

2,300p

11.7

Diluted adjusted#‡

2,566p

2,297p

11.7

Mid-market price of the 5p Ordinary Shares

2,043p

1,845p

10.7

Discount to diluted net asset value

19.1%

18.3%

 

Discount to diluted adjusted net asset value

20.4%

19.7%

 

Standard & Poor's 500 Composite Index†

1,346.7

1,324.7

1.7

Russell 2000 Index†

792.9

773.8

2.5

FTSE All-Share Index

3,652.8

3,621.8

0.9

US Dollar/Sterling exchange rate

1.5605

1.5019

3.9

* Including retained revenue for the period.

# Adjusted to reflect Oryx International Growth Fund plc ("Oryx") under the equity method of accounting, which is how the Company previously accounted for its share of Oryx, prior to the adoption of IFRS 10.

‡ Calculated using the adjusted Net Assets per note 5.

† Sterling adjusted.

 

 

chief executive's review

During the six month period to 31 July 2015, the fully diluted net asset value of the Company rose by 11.8% as compared to a rise in the sterling adjusted Standard & Poor's 500 Composite Index of +1.7% and the FTSE Small Cap Index of +6.5%.

Income for the period amounted to a loss of £688,000 (31 July 2014: loss of £1,220,000). Consistent with past policy, the Directors do not propose to pay a dividend (31 July 2014: nil).

quoted portfolio

The market for small companies in the UK has generally been robust which benefitted our holding in Oryx which rose by 17.7%, significantly outperforming its benchmark index.

Our very substantial holding in MJ Gleeson Group also performed notably well, rising by nearly 25% over the period. Nationwide Accident Repair Services and Essenden were both taken over on premiums of 28% and 23% respectively to the 31 January 2015 valuation, whilst Bioquell performed very strongly following the sale of a subsidiary, rising by nearly 65%. The only notable faller in the UK was Goals Soccer Centres which fell approximately 7%. Finally, Mecom Group was taken over at a good premium to cost whilst OMG announced substantial special dividends as a return of capital.

In the US a modest position was taken in Ambac Financial Group, although to date the performance has been disappointing.

unquoted portfolio

There has been considerable activity in the unquoted portfolio, with Celsis AG in particular being sold in July 2015 at a 50% premium to the 31 January 2015 valuation.

Avenue Financial went public and is currently trading at approximately a 26% premium to the 31 January 2015 valuation, whilst the B&G Equipment valuation was increased, reflecting good trading performance. Performance Chemical Company, despite the weak oil price, continues to achieve good profitability. The Bionostics Holdings escrow of approximately £4.0 million was received in full.

Trident Private Equity Fund II was, to all intents and purposes, liquidated. It was, however, necessary to modestly write down Hampton Investment Properties due to the disappointing realisation of properties. It is expected that this investment will be turned into cash by 31 January 2016, being the Company's year-end.

outlook

Since 31 July 2015, markets have been extremely weak. However, the Company has for some time been very conservatively invested with cash balances in excess of 30% of our net assets. Although this adversely impacted performance in the first half of the year, it will hopefully protect the portfolio during the current turbulence and provide the resources with which to participate in new opportunities as they arise.

C H B Mills

Chief Executive

10 September 2015

 

top ten investments

as at 31 July 2015

Company

Fair

value

£'000

% of

net assets

US Treasury Bills

US Treasury Stock

65,643

17.9

MJ Gleeson Group plc

UK Listed

45,400

12.4

Oryx International Growth Fund Limited

UK Listed

39,440

10.7

Trident Private Equity Fund III LP

UK Unquoted

20,543

5.6

Industrial Properties Limited

UK Unquoted

14,000

3.8

Bioquell PLC

UK Listed

13,348

3.6

Goals Soccer Centres plc

UK Quoted on AIM

12,672

3.4

Innovation Group PLC

UK Listed

11,288

3.1

AssetCo plc

UK Quoted on AIM

10,373

2.8

Team Rock Limited

UK Unquoted

10,108

2.8

242,815

66.1

 

 

interim management report

investment objective

The objective of North Atlantic Smaller Companies Investment Trust PLC ("the Company") is to provide capital appreciation through investment in a portfolio of smaller companies principally based in countries bordering the North Atlantic Ocean.

material events

The Board do not consider that there were any material events during the period ended 31 July 2015.

material transactions

As referred to in the Chief Executive's review, the Company's investment in Celsis AG was sold during the period under review.

risk profile

The principal risks and uncertainties for the remaining six months of the year continue to be as described in the Annual Report for the year ended 31 January 2015. The principal risks arising from the Company's financial instruments are market price risk, including currency risk interest rate risk and other price risk, liquidity risk and credit/counterparty risk. The Directors review and agree policies with the Manager, Harwood Capital LLP, for managing these risks. The policies have remained substantially unchanged in the six months since the year end.

The Group does not have any significant exposure to credit risk arising from any one individual party. Credit risk is spread across a number of companies, each having an immaterial effect on the Group's cash flows, should a default occur. The Group assesses the credit worthiness of its debtors from time to time to ensure that they are neither past due or impaired.

To support its investment in unquoted companies, the Group may periodically agree to guarantee all or part of the borrowings of investee companies. Provision is made for any costs that may be incurred when the Directors consider it likely that the guarantee will crystallise.

The Group's exposure to market price risk comprises mainly movements in the value of the Group's investments. It should be noted that the prices of options tend to be more volatile than the prices of the underlying securities. The Manager assesses the exposure to market risk when making each investment decision and monitors the overall level of market risk on the whole of the investment portfolio on an ongoing basis.

The functional and presentational currency of the Group is Sterling, and therefore, the Group's principal exposure to foreign currency risk comprises investments priced in other currencies, principally US Dollars.

The Group invests in equities and other investments that are realisable.

related party transactions

These are listed in note 10 to the half yearly condensed financial statements.

By Order of the Board

Peregrine Moncreiffe

Chairman

10 September 2015

 

responsibility statement

The Directors confirm to the best of their knowledge that:

· The condensed set of financial statements contained within this half yearly financial report have been prepared in accordance with International Accounting Standard 34 'Interim Financial Reporting' as adopted by the European Union and gives a true and fair view of the assets, liabilities, financial position and profit of the Group; and

· The half yearly financial report includes a fair review of the information required by the FCA's Disclosure and Transparency Rule 4.2.7R being disclosure of important events that have occurred during the first six months of the financial year, their impact on the condensed set of financial statements and a description of the principal risks and uncertainties for the remaining six months of the year; and

· The half yearly financial report includes a fair review of the information required by the FCA's Disclosure and Transparency Rule 4.2.8R being disclosure of related party transactions during the first six months of the financial year, how they have materially affected the financial position of the Company during the period and any changes therein.

The half yearly financial report was approved by the Board on 10 September 2015 and the above responsibility statement was signed on its behalf by:

Peregrine Moncreiffe

Chairman

10 September 2015

 

condensed consolidated statement of comprehensive income

 

Six months ended

31 July

2015

(unaudited)

Six months ended

31 July

2014

(unaudited)

Year ended

31 January

2015

(audited)

Revenue 

£'000 

Capital 

£'000 

Total 

£'000 

Revenue 

£'000 

Capital 

£'000 

Total 

£'000 

Revenue 

£'000 

Capital

£'000

Total 

£'000 

Income

1,279 

1,279 

860 

- 

860 

1,840 

-

1,840 

Net gains on investments at fair value

40,432 

40,432 

- 

11,427 

11,427 

- 

37,873

37,873 

Currency exchange (losses)/gains

(70)

(70)

- 

(119)

(119)

- 

270

270 

total income

1,279 

40,362 

41,641 

860 

11,308 

12,168 

1,840 

38,143

39,983 

Expenses

Investment management fee (note 10)

(1,672)

(937)

(2,609)

(1,632)

26 

(1,606)

(3,263)

79

(3,184)

Other expenses

(281)

(281)

(261)

- 

(261)

(574)

-

(574)

Share based remuneration

(7)

(7)

(180)

- 

(180)

(173)

-

(173)

return before finance costs and taxation

(681)

39,425 

38,744 

(1,213)

11,334 

10,121 

(2,170)

38,222

36,052 

Finance costs

- 

- 

- 

- 

-

- 

return before taxation

(681)

39,425 

38,744 

(1,213)

11,334 

10,121 

(2,170)

38,222

36,052 

Taxation

(7)

(7)

(7)

- 

(7)

(12)

-

(12)

return for the period

(688)

39,425 

38,737 

(1,220)

11,334 

10,114 

(2,182)

38,222

36,040 

earnings per ordinary share (note 4)

Basic

266.4p

65.6p

240.3p

Diluted

266.2p

65.3p

240.3p

 

The total column of the statement is the Statement of Comprehensive Income of the Group prepared in accordance with International Financial Reporting Standards ("IFRS"). The supplementary revenue and capital columns are presented for information purposes as recommended by the Statement of Recommended Practice issued by the Association of Investment Companies ("AIC").

All items in the above Statement derive from continuing operations. No operations were acquired or discontinued in the period.

 

condensed consolidated statement of changes in equity

 

Share 

capital 

£'000 

Share 

options 

reserve 

£'000 

Share

premium

account

£'000

Capital

reserve

£'000

Capital

redemption

reserve

£'000

Revenue 

reserve 

£'000 

Total 

£'000 

six months ended 31 July 2015 (unaudited)

31 January 2015

727 

293 

1,301

333,262

143

(6,822)

328,904 

Total comprehensive income for the period

- 

- 

-

39,425

-

(688)

38,737 

Share option discharge

- 

(15)

-

(88)

-

- 

(103)

Shares purchased for cancellation

- 

- 

-

-

-

- 

- 

Share options expenses

- 

7 

-

-

-

- 

7 

31 July 2015

727 

285 

1,301

372,599

143

(7,510)

367,545 

six months ended 31 July 2014 (unaudited)

31 January 2014*

794 

1,138 

1,301

319,888

76

(4,640)

318,557 

Total comprehensive income for the period

-

11,334

-

(1,220)

10,114 

Shares purchased for cancellation

(53)

-

(18,080)

53

(18,080)

Share options expenses

180 

-

-

-

180 

31 July 2014

741 

1,318 

1,301

313,142

129

(5,860)

310,771 

year ended 31 January 2015 (audited)

31 January 2014*

794 

1,138 

1,301

319,888

76

(4,640)

318,557 

Total comprehensive income for the year

-

38,222

-

(2,182)

36,040 

Share option discharge

(1,018)

-

(2,081)

-

(3,099)

Shares purchased for cancellation

(67)

-

(22,767)

67

(22,767)

Share option expenses

173 

-

-

-

173 

31 January 2015

727 

293 

1,301

333,262

143

(6,822)

328,904 

 

* restated due to the adoption of IFRS 10. The Company is no longer required to consolidate investment entities, as explained in the Accounting Policies (note 1) in the Annual Report for the year end 31 January 2015.

 

condensed consolidated balance sheet

 

31 July 

2015 

(unaudited) 

£'000 

31 July 

2014 

(unaudited) 

£'000 

31 January 

2015 

(audited) 

£'000 

non current assets

Investments at fair value through profit or loss

314,656 

283,929 

321,044 

314,656 

283,929 

321,044 

current assets

Trade and other receivables

809 

732 

562 

Cash and cash equivalents

53,489 

26,398 

7,598 

54,298 

27,130 

8,160 

total assets

368,954 

311,059 

329,204 

current liabilities

Trade and other payables

(1,409)

(288)

(300)

total liabilities

(1,409)

(288)

(300)

total assets less current liabilities

367,545 

310,771 

328,904 

net assets

367,545 

310,771 

328,904 

represented by:

Share capital

727 

741 

727 

Share options reserve

285 

1,318 

293 

Share premium account

1,301 

1,301 

1,301 

Capital reserve

372,599 

313,142 

333,262 

Capital redemption reserve

143 

129 

143 

Revenue reserve

(7,510)

(5,860)

(6,822)

total equity attributable to equity holders of the Company

367,545 

310,771 

328,904 

net asset value per ordinary share (note 5):

Basic

2,527p

2,097p

2,262p

Diluted

2,525p

2,078p

2,259p

 

 

condensed consolidated cash flow statement

 

Six months 

ended 31 July 

2015 

(unaudited) 

£'000 

Six months 

ended 31 July 

2014 

(unaudited) 

£'000 

Year ended 

31 January 

2015 

(audited) 

£'000 

cash flows from operating activities

Investment income received

861 

880 

1,658 

Bank deposit interest received

28 

37 

Other income

425 

34 

215 

Investment Manager's fees paid

(1,739)

(3,364)

(5,058)

Other cash payments

(321)

(559)

(3,633)

cash expended from operations (note 7)

(774)

(2,981)

(6,781)

Taxation paid

(7)

(7)

(12)

net cash outflow from operating activities

(781)

(2,988)

(6,793)

cash flows from investing activities

Purchases of investments

(186,975)

(109,537)

(309,650)

Sales of investments

233,790 

129,588 

319,054 

net cash inflow from investing activities

46,815 

20,051 

9,404 

cash flows from financing activities

Repurchase of ordinary shares for cancellation

(18,068)

(22,769)

net cash outflow from financing activities

(18,068)

(22,769)

increase/(decrease) in cash and cash equivalents for the period

46,034 

(1,005)

(20,158)

cash and cash equivalents at the start of the period

7,598 

27,511 

27,511 

Revaluation of foreign currency balances

(143)

(108)

245 

cash and cash equivalents at the end of the period

53,489 

26,398 

7,598 

 

 

notes

1. a) general information

North Atlantic Smaller Companies Investment Trust plc ("NASCIT") is a Company incorporated in Great Britain and registered in England and Wales under the Companies Acts 1948 to 1967.

The Company operates as an investment trust company within the meaning of Section 833 of the Companies Act 2006 and has made a successful application under Regulation 5 of the Investment Trust (Approved Company) (Tax) Regulations 2011 for investment trust status to apply to all accounting periods starting on or after 1 February 2013. The Company is managed in such a way to ensure that it continues to meet the eligibility conditions contained in Section 1158 of the Corporation Tax Act 2010 and the ongoing requirements outlined in Chapter 3 of Part 2 of the regulations.

b) basis of preparation

The condensed consolidated interim financial statements for the six months ended 31 July 2015 have been prepared in accordance with IAS 34 "Interim Financial Reporting". They do not include all financial information required for full annual financial statements and have been prepared using the accounting policies adopted in the audited financial statements for the year ended 31 January 2015. Those financial statements were prepared in accordance with IFRS and with the Statement of Recommended Practice ('SORP') for Investment Companies and Venture Capital Trusts issued by the AIC in November 2014.

The condensed consolidated interim financial information includes the financial statements of the Company and its wholly owned Subsidiary, Consolidated Venture Finance Limited, for the six months ended 31 July 2015.

c) significant accounting policies

The accounting policies applied are consistent with those of the Annual Financial Report for the year ended 31 January 2015. Since the year end no new standards have been adopted.

d) segmental reporting

The Directors are of the opinion that the Group is engaged in a single segment of business, being investment business. The Group invests in smaller companies principally based in countries bordering the North Atlantic Ocean.

e) going concern

The Company has adequate financial resources and no significant investment commitments and as a consequence, the Directors believe that the Company is well placed to manage its business risks successfully. After making appropriate enquiries, the Directors have a reasonable expectation that the Company has adequate available financial resources to continue in operational existence for the foreseeable future and accordingly have concluded that it is appropriate to continue to adopt the going concern basis in preparing this half yearly financial report.

2. investment management and performance fees

A Performance Fee is only payable if the investment portfolio, including Oryx at the adjusted price, outperforms the Sterling adjusted Standard & Poor's 500 Composite Index at the end of each financial year and is limited to a maximum payment of 0.5% of Shareholders' Funds, and is allocated 100% to capital.

In accordance with the SORP for investment trust companies, an amount is included in these financial statements for the Performance Fee that could be payable based on investment performance to 31 July 2015.

At that date, a Performance Fee has been accrued for in the accounts amounting to £937,000 (31 July 2014: £nil; 31 January 2015: £nil).

3. taxation

The Company has an effective tax rate of 0%. The estimated effective tax rate is 0% as investment gains are exempt from tax owing to the Company's status as an Investment Trust and there is expected to be an excess of management expenses over taxable income and thus there is no charge for corporation tax.

 

4. return per ordinary share

 

*Net 

return 

£'000 

Revenue

 

Ordinary

Shares

Per

Share

pence

*Net

return

£'000

Capital

 

Ordinary

Shares

Per

Share

pence

*Net

return

£'000

Total

 

Ordinary

Shares

Per

Share

pence

six months ended 31 July 2015 (unaudited)

Basic return

(688)

14,542,035

(4.7)

39,425

14,542,035

271.1

38,737

14,542,035

266.4

Share options**

- 

10,442

-

10,442

-

10,442

Diluted return

(688)

14,552,477

(4.7)

39,425

14,552,477

270.9

38,737

14,552,477

266.2

six months ended 31 July 2014 (unaudited)

Basic return

(1,220)

15,409,406

(7.9)

11,334

15,409,406

73.5

10,114

15,409,406

65.6

CULS***

66,957

-

66,957

-

66,957

Diluted return

(1,220)

15,476,363

(7.9)

11,334

15,476,363

73.2

10,114

15,476,363

65.3

year ended 31 January 2015 (audited)

Basic return

(2,182)

14,996,362

(14.6)

38,222

14,996,362

254.9

36,040

14,996,362

240.3

Share options**

-

-

-

-

-

Diluted return

(2,182)

14,996,362

(14.6)

38,222

14,996,362

254.9

36,040

14,996,362

240.3

 

Basic return per Ordinary Share has been calculated using the weighted average number of Ordinary Shares in issue during the period.

* Net return on ordinary activities attributable to Ordinary Shareholders.

** Excess of total number of potential shares on Option Conversion over the number that could be issued at the average market price, as calculated in accordance with IAS 33: Earnings per share.

*** CULS interest cost and excess of the total number of potential shares on CULS conversion over the number that could have been issued at the average market price from the conversion proceeds, as calculated in accordance with IAS 33: Earnings per share.

 

 

5. net asset value per ordinary share

The basic net asset value per Ordinary Share is based on net assets of £367,545,000 (31 July 2014: £310,771,000; 31 January 2015: £328,904,000) and on 14,542,035 Ordinary Shares (31 July 2014: 14,817,035; 31 January 2015: 14,542,035) being the number of Ordinary Shares in issue at the period end.

The diluted net asset value per Ordinary Share is calculated on the assumption that all 30,000 (31 July 2014: 460,000; 31 January 2015: 40,000) Share Options in-the-money were exercised at the prevailing exercise prices, giving a total of 14,572,035 issued Ordinary Shares (31 July 2014: 15,277,035; 31 January 2015: 14,582,035).

During the period, no Ordinary Shares were bought back for cancellation.

adjustment for Oryx International Growth Fund

On adoption of IFRS 10, the Company has changed its method of accounting for its investment in Oryx. It was previously priced using equity accounting to account for the Company's share of Oryx's net assets. It is now valued using fair value, derived from the share price which is materially different to the value derived from equity accounting.

The below table shows the effect on the net assets of the change in method.

31 July 2015

(unaudited)

£'000

31 July 2014

(unaudited)

£'000

31 January 2015

(audited)

£'000

Total equity attributable to equity holders of the Company

367,545

310,771

328,904

Increase in net assets if equity accounted*

5,898

8,989

5,543

Adjusted net assets

373,443

319,760

334,447

 

* increase in net gains on investments at fair value/increase in value of investments at fair value through profit or loss..

31 July 2015

(unaudited)

31 July 2014

(unaudited)

31 January 2015

(audited)

Net asset value

- Basic

2,527p

2,097p

2,262p

- Diluted

2,525p

2,078p

2,259p

Net asset value adjusted

- Basic

2,568p

2,158p

2,300p

- Diluted

2,566p

2,137p

2,297p

 

6. share based remuneration

As at 31 July 2015 and as at the date of this report, there were a total of 30,000 options in issue with an estimated fair value of £0.4m (31 July 2014: 460,000; 31 January 2015: 40,000). 10,000 options are under the 2011 options scheme and 20,000 options are under the 2012 option scheme.

 

7. reconciliation of total return from ordinary activities before finance costs and taxation to cash expended from operations

 

Six months 

ended 31 July 

2015 

(unaudited) 

£'000 

Six months 

ended 31 July 

2014 

(unaudited) 

£'000 

Year ended 

31 January 

2015 

(audited) 

£'000 

Total return from ordinary activities before finance costs and taxation

38,744 

10,121 

36,052 

Gains on investments

(40,362)

(11,308)

(38,143)

Share options discharge

(103)

(3,099)

Share based remuneration

7 

180 

173 

Dividends and interest reinvested

- 

77 

78 

(Increase)/decrease in debtors and accrued income

(186)

(65)

120 

Increase/(decrease) in creditors and accruals

1,126 

(1,989)

(1,961)

Changes relating to investments of dealing Subsidiary

- 

(1)

Cash expended from operations

(774)

(2,981)

(6,781)

 

8. investments

The Company adopted the amendment to IFRS 13, effective 1 January 2009. This requires the Company to classify fair value measurements using a fair value hierarchy that reflects the significance of the inputs used in making the measurements. The fair value hierarchy consists of the following three levels:

· Level 1 - Quoted prices (unadjusted) in active markets for identical assets or liabilities (Level 1).

An active market is a market in which transactions for the asset or liability occur with sufficient frequency and volume on an ongoing basis such that quoted prices reflect prices at which an orderly transaction would take place between market participants at the measurement date. Quoted prices provided by external pricing services, brokers and vendors are included in Level 1, if they reflect actual and regularly occurring market transactions on an arms length basis.

· Level 2 - Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly (that is, as prices) or indirectly (that is, derived from prices).

· Level 3 - Inputs for the asset or liability that are not based on observable market data (unobservable inputs).

The Company's main unobservable inputs are earnings multiples, recent transactions and net asset basis. The market value would be sensitive to movements in these unobservable inputs. Movements in these inputs, individually or in aggregate could have a significant effect on the market value. The effect of such a change or a reasonable possible alternative would be difficult to quantify as such data is not available.

The level in the fair value hierarchy within which the fair value measurement is categorised in its entirety is determined on the basis of the lowest level input that is significant to the fair value measurement in its entirety. For this purpose, the significance of an input is assessed against the fair value measurement in its entirety. If a fair value measurement uses observable inputs that require significant adjustment based on unobservable inputs, that measurement is a Level 3 measurement. Assessing the significance of a particular input to the fair value measurement in its entirety requires judgement, considering factors specific to the asset or liability.

The determination of what constitutes 'observable' requires significant judgement by the Company. The Company considers observable data from investments actively traded in organised financial markets, fair value is generally determined by reference to Stock Exchange quoted market bid prices at the close of business on the Balance Sheet date, without adjustment for transaction costs necessary to realise the asset.

financial assets at fair value through profit or loss

The table below sets out fair value measurements of financial assets in accordance with the IFRS 13 fair value hierarchy system:

group

six months ended 31 July 2015 (unaudited)

Total

£'000

Level 1

£'000

Level 2

£'000

Level 3

£'000

Equity investments

227,352

153,087

2,050

72,215

Fixed interest investments

87,304

65,643

-

21,661

Total

314,656

218,730

2,050

93,876

 

six months ended 31 July 2014 (unaudited)

Total

£'000

Level 1

£'000

Level 2

£'000

Level 3

£'000

Equity investments

224,963

127,212

1,580

96,171

Fixed interest investments

58,966

53,010

-

5,956

Total

283,929

180,222

1,580

102,127

 

year ended 31 January 2015 (audited)

Total

£'000

Level 1

£'000

Level 2

£'000

Level 3

£'000

Equity investments

236,596

126,681

1,480

108,435

Fixed interest investments

84,448

65,583

-

18,865

Total

321,044

192,264

1,480

127,300

 

 

level 3 financial assets at fair value through profit or loss

A reconciliation of fair value measurements in Level 3 is set out below:

group

at 31 July 2015

Total 

£'000 

Equity 

investments 

£'000

Fixed interest 

investments 

£'000 

Opening Balance

127,300 

108,435 

18,865 

Purchases

2,867 

37 

2,830 

Sales

(50,069)

(50,069)

Transfer*

(610)

(610)

Total gains/(losses) included in gains on investments in the statement of comprehensive income:

- on assets sold

32,678 

32,702 

(24)

- on assets held at the end of the period

(18,290)

(18,280)

(10)

Closing balance

93,876 

72,215 

21,661 

 

* Transfer out of level 3 to level 1.

First American Holdings was acquired, as part of an initial public offering, by Avenue Financial Holdings Inc. in the period, resulting in a move from unlisted (level 3) to listed (level 1).

9. principal risk profile

The principal risks which the Company faces include exposure to:

(i) market price risk, including currency risk, interest rate risk and other price risk;

(ii) liquidity risk; and

(iii) credit risk.

Further details of the Company's management of these risks and exposure to them is set out in Note 14 of the Company's Annual Report for the year ended 31 January 2015, as issued on 14 May 2015. There have been no changes to the management of or exposure to these risks since that date.

 

10. related party transactions

There have been no changes to the related party arrangements or transactions as reported in the Statutory Annual Financial Report for the year ended 31 January 2015.

The Manager, Harwood Capital LLP, is regarded as a related party of the Company. The amounts payable to the Manager and Growth Financial Services Limited in respect of investment management for the six months to 31 July 2015 are as follows:

Six months

ended 31 July

2015

(unaudited)

£'000

Six months 

ended 31 July 

2014 

(unaudited) 

£'000

Year ended

31 January

2015

(audited)

£'000

Annual fee

1,672

1,632 

3,263

Performance fee

930

-

Irrecoverable VAT thereon

7

(26)

(79)

2,609

1,606 

3,184

 

In addition to the management fees disclosed above, Harwood Capital LLP is also paid an investment management related fee of £125,000 per annum.

The figure for the performance fee disclosed above, is a provision for six months based on the outperformance as at 31 July 2015 and is therefore subject to change.

Shareholders should also note the payments made under share based remuneration as disclosed in note 6 to these financial statements.

11. financial information

The annual financial information contained in this half yearly report does not constitute full Statutory accounts as defined in Section 434 of the Companies Act 2006. The financial information for the periods ended 31 July 2015 and 31 July 2014 is not a financial year and has not been audited. The statutory accounts for the financial year ended 31 January 2015 have been delivered to the Registrar of Companies.

 

 

shareholder information

financial calendar

Announcement of results and annual report May

Annual General Meeting June

Half Yearly figures announced September

Half Yearly Report posted September

share price

The Company's mid-market share price is quoted daily in the Financial Times appearing under "Investment Companies".

It also appears on:

SEAQ Ordinary Shares: NAS

Trustnet: www.trustnet.ltd.uk

net asset value

The latest net asset value of the Company can be found on the Harwood Capital LLP website: www.harwoodcapital.co.uk

share dealing

Investors wishing to purchase more Ordinary Shares or dispose of all or part of their holding may do so through a stockbroker. Many banks also offer this service.

The Company's registrars are Capita Asset Services. In the event of any queries regarding your holding of shares, please contact the registrars on: 0871 664 0300, or by email on shareholderenquiries@capita.co.uk

Changes of name or address must be notified to the registrars in writing at:

Capita Asset Services

The Registry

34 Beckenham Road

Beckenham

Kent BR3 4TU

Directors

Peregrine Moncreiffe (Chairman)

Christopher Mills (Chief Executive)

Kristian Siem

Charles Irby

Enrique Foster Gittes

Manager

Harwood Capital LLP

(Authorised and regulated by the Financial Conduct Authority)

6 Stratton Street

Mayfair

London W1J 8LD

Telephone: 020 7640 3200

Financial Adviser and Stockbroker

Winterflood Investment Trusts

The Atrium Building

Cannon Bridge

25 Dowgate Hill

London EC4R 2GA

 

Registered Office

6 Stratton Street

Mayfair

London W1J 8LD

Telephone: 020 7640 3200

Registrars

Capita Asset Services

34 Beckenham Road

Beckenham

Kent BR3 4TU

Auditors

KPMG LLP

15 Canada Square

London E14 5GL

Company Secretary

Derringtons Limited

Hyde Park House

5 Manfred Road

London SW15 2RS

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR MMGMLNGGGKZM
Date   Source Headline
17th Apr 202410:52 amRNSNet Asset Value(s)
12th Apr 20243:48 pmRNSHolding(s) in Company
8th Apr 20249:42 amRNSTransaction in Own Shares
2nd Apr 20247:00 amRNSTransaction in Own Shares
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 202412:45 pmRNSTransaction in Own Shares - Replacement
21st Mar 20247:00 amRNSTransaction in Own Shares
20th Mar 20243:55 pmRNSNet Asset Value(s)
15th Mar 202410:01 amRNSHolding(s) in Company
27th Feb 20247:00 amRNSDirector/PDMR Shareholding
19th Feb 202411:07 amRNSTransaction in Own Shares
19th Feb 20247:00 amRNSDividend Declaration
15th Feb 20247:00 amRNSNet Asset Value(s)
8th Feb 20247:00 amRNSTransaction in Own Shares
5th Feb 20249:14 amRNSNew Investment: Crest Foods
5th Feb 20247:00 amRNSTransaction in Own Shares
31st Jan 20247:00 amRNSDirector/PDMR Shareholding
17th Jan 20243:32 pmRNSNet Asset Value(s)
27th Dec 20237:00 amRNSDirector Declaration
19th Dec 20237:00 amRNSNet Asset Value(s)
6th Dec 20237:41 amRNSInvestment Update: Ten Entertainment Group Plc
16th Nov 202312:44 pmRNSNet Asset Value(s)
30th Oct 20232:30 pmRNSTransaction in Own Shares
23rd Oct 20232:10 pmRNSTransaction in Own Shares
16th Oct 202312:19 pmRNSNet Asset Value(s)
12th Oct 20238:43 amRNSReplacement: Private Equity Investment Disposal
12th Oct 20237:00 amRNSPrivate Equity investment disposal
9th Oct 20233:02 pmRNSTransaction in Own Shares
15th Sep 20237:00 amRNSHalf-year Report
14th Sep 20231:43 pmRNSNet Asset Value(s)
31st Aug 20234:40 pmRNSCompany Secretary Change
29th Aug 20233:46 pmRNSTransaction in Own Shares - Replacement
29th Aug 20232:49 pmRNSTransaction in Own Shares
21st Aug 20233:07 pmRNSTransaction in Own Shares
16th Aug 20234:15 pmRNSTransaction in Own Shares
15th Aug 202310:03 amRNSNet Asset Value(s)
14th Aug 20232:09 pmRNSTransaction in Own Shares
8th Aug 20234:30 pmRNSTransaction in Own Shares
7th Aug 20234:28 pmRNSTransaction in Own Shares
25th Jul 202312:52 pmRNSNanoco Group Plc
18th Jul 20233:23 pmRNSNet Asset Value(s)
17th Jul 202312:41 pmRNSPortfolio Update
10th Jul 20239:39 amRNSTransaction in Own Shares
3rd Jul 202310:14 amRNSTransaction in Own Shares
30th Jun 202312:17 pmRNSDirector/PDMR Shareholding
26th Jun 202310:00 amRNSTransaction in Own Shares
21st Jun 20237:00 amRNSResult of AGM
15th Jun 20231:15 pmRNSNet Asset Value(s)
26th May 20235:10 pmRNSDirectorate Change
22nd May 20231:37 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.